[Study on T cell subsets and their activated molecules from the convalescent SARS patients during two follow-up surveys].
Identifieur interne : 002878 ( PubMed/Checkpoint ); précédent : 002877; suivant : 002879[Study on T cell subsets and their activated molecules from the convalescent SARS patients during two follow-up surveys].
Auteurs : Cui Cai [République populaire de Chine] ; Xing Zeng ; Ai-Hua Ou ; Yu Huang ; Xian ZhangSource :
- Xi bao yu fen zi mian yi xue za zhi = Chinese journal of cellular and molecular immunology [ 1007-8738 ] ; 2004.
Descripteurs français
- KwdFr :
- MESH :
English descriptors
- KwdEn :
- MESH :
- chemical , metabolism : CD3 Complex, CD4 Antigens, CD8 Antigens.
- immunology : Severe Acute Respiratory Syndrome, T-Lymphocyte Subsets.
- CD4-CD8 Ratio, Convalescence, Flow Cytometry, Follow-Up Studies, Humans, Lymphocyte Count.
Abstract
To explore the changes of peripheral blood T cell subsets and their activated molecules in convalescent SARS patients.
PubMed: 15193228
Affiliations:
Links toward previous steps (curation, corpus...)
Links to Exploration step
pubmed:15193228Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">[Study on T cell subsets and their activated molecules from the convalescent SARS patients during two follow-up surveys].</title><author><name sortKey="Cai, Cui" sort="Cai, Cui" uniqKey="Cai C" first="Cui" last="Cai">Cui Cai</name><affiliation wicri:level="1"><nlm:affiliation>The Central Laboratory, Guangdong Provincial Hospital of TCM, Guangzhou 510120, China. X-Zeng@21cn.com</nlm:affiliation><country xml:lang="fr">République populaire de Chine</country><wicri:regionArea>The Central Laboratory, Guangdong Provincial Hospital of TCM, Guangzhou 510120</wicri:regionArea><placeName><settlement type="city">Jiangmen</settlement><region type="province">Guangdong</region></placeName></affiliation></author><author><name sortKey="Zeng, Xing" sort="Zeng, Xing" uniqKey="Zeng X" first="Xing" last="Zeng">Xing Zeng</name></author><author><name sortKey="Ou, Ai Hua" sort="Ou, Ai Hua" uniqKey="Ou A" first="Ai-Hua" last="Ou">Ai-Hua Ou</name></author><author><name sortKey="Huang, Yu" sort="Huang, Yu" uniqKey="Huang Y" first="Yu" last="Huang">Yu Huang</name></author><author><name sortKey="Zhang, Xian" sort="Zhang, Xian" uniqKey="Zhang X" first="Xian" last="Zhang">Xian Zhang</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2004">2004</date><idno type="RBID">pubmed:15193228</idno><idno type="pmid">15193228</idno><idno type="wicri:Area/PubMed/Corpus">002D42</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">002D42</idno><idno type="wicri:Area/PubMed/Curation">002D42</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">002D42</idno><idno type="wicri:Area/PubMed/Checkpoint">002878</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">002878</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">[Study on T cell subsets and their activated molecules from the convalescent SARS patients during two follow-up surveys].</title><author><name sortKey="Cai, Cui" sort="Cai, Cui" uniqKey="Cai C" first="Cui" last="Cai">Cui Cai</name><affiliation wicri:level="1"><nlm:affiliation>The Central Laboratory, Guangdong Provincial Hospital of TCM, Guangzhou 510120, China. X-Zeng@21cn.com</nlm:affiliation><country xml:lang="fr">République populaire de Chine</country><wicri:regionArea>The Central Laboratory, Guangdong Provincial Hospital of TCM, Guangzhou 510120</wicri:regionArea><placeName><settlement type="city">Jiangmen</settlement><region type="province">Guangdong</region></placeName></affiliation></author><author><name sortKey="Zeng, Xing" sort="Zeng, Xing" uniqKey="Zeng X" first="Xing" last="Zeng">Xing Zeng</name></author><author><name sortKey="Ou, Ai Hua" sort="Ou, Ai Hua" uniqKey="Ou A" first="Ai-Hua" last="Ou">Ai-Hua Ou</name></author><author><name sortKey="Huang, Yu" sort="Huang, Yu" uniqKey="Huang Y" first="Yu" last="Huang">Yu Huang</name></author><author><name sortKey="Zhang, Xian" sort="Zhang, Xian" uniqKey="Zhang X" first="Xian" last="Zhang">Xian Zhang</name></author></analytic><series><title level="j">Xi bao yu fen zi mian yi xue za zhi = Chinese journal of cellular and molecular immunology</title><idno type="ISSN">1007-8738</idno><imprint><date when="2004" type="published">2004</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>CD3 Complex (metabolism)</term><term>CD4 Antigens (metabolism)</term><term>CD4-CD8 Ratio</term><term>CD8 Antigens (metabolism)</term><term>Convalescence</term><term>Flow Cytometry</term><term>Follow-Up Studies</term><term>Humans</term><term>Lymphocyte Count</term><term>Severe Acute Respiratory Syndrome (immunology)</term><term>T-Lymphocyte Subsets (immunology)</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Convalescence</term><term>Cytométrie en flux</term><term>Humains</term><term>Numération des lymphocytes</term><term>Rapport CD4-CD8</term><term>Sous-populations de lymphocytes T (immunologie)</term><term>Syndrome respiratoire aigu sévère (immunologie)</term><term>Études de suivi</term></keywords><keywords scheme="MESH" type="chemical" qualifier="metabolism" xml:lang="en"><term>CD3 Complex</term><term>CD4 Antigens</term><term>CD8 Antigens</term></keywords><keywords scheme="MESH" qualifier="immunologie" xml:lang="fr"><term>Sous-populations de lymphocytes T</term><term>Syndrome respiratoire aigu sévère</term></keywords><keywords scheme="MESH" qualifier="immunology" xml:lang="en"><term>Severe Acute Respiratory Syndrome</term><term>T-Lymphocyte Subsets</term></keywords><keywords scheme="MESH" xml:lang="en"><term>CD4-CD8 Ratio</term><term>Convalescence</term><term>Flow Cytometry</term><term>Follow-Up Studies</term><term>Humans</term><term>Lymphocyte Count</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Convalescence</term><term>Cytométrie en flux</term><term>Humains</term><term>Numération des lymphocytes</term><term>Rapport CD4-CD8</term><term>Études de suivi</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">To explore the changes of peripheral blood T cell subsets and their activated molecules in convalescent SARS patients.</div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">15193228</PMID><DateCompleted><Year>2004</Year><Month>12</Month><Day>14</Day></DateCompleted><DateRevised><Year>2017</Year><Month>11</Month><Day>16</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">1007-8738</ISSN><JournalIssue CitedMedium="Print"><Volume>20</Volume><Issue>3</Issue><PubDate><Year>2004</Year><Month>May</Month></PubDate></JournalIssue><Title>Xi bao yu fen zi mian yi xue za zhi = Chinese journal of cellular and molecular immunology</Title><ISOAbbreviation>Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi</ISOAbbreviation></Journal><ArticleTitle>[Study on T cell subsets and their activated molecules from the convalescent SARS patients during two follow-up surveys].</ArticleTitle><Pagination><MedlinePgn>322-4</MedlinePgn></Pagination><Abstract><AbstractText Label="AIM" NlmCategory="OBJECTIVE">To explore the changes of peripheral blood T cell subsets and their activated molecules in convalescent SARS patients.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">In two follow-up surveys of the SARS patients discharged from our hospital, the changes of CD3(+), CD4(+), CD8(+), CD8(+) CD28(+), CD8(+) CD28(-), CD3(+) CD25(+), CD3(+) CD69(+), CD3(+) HLA-DR(+)T cells and the ratio of CD4(+)/CD8(+) T cells in peripheral blood of SARS patients treated unitedly with Chinese and Western medicines were detected by flow cytometry.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">In two follow-up surveys, the percentages of CD3(+), CD4(+), CD8(+) CD28(+) T cells and the ratio of CD4(+)/CD8(+) T cells were remarkably lower than those of normal values(P<0.05), while the percentage of CD8(+) CD28 (-) T cells was higher(P<0.01). As for the percentages of CD3(+), CD8(+), CD4(+)/CD8(+), CD3(+) CD25(+), CD3(+) CD69(+) and CD3(+) HLA-DR(+) T cells, there was marked difference between 1st and 2nd follow-up results, but for other molecules there was no notable difference.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">The convalescent SARS patients' immune function gradually recovers, and the effect of SARS virus on activation of T cells gradually disappears.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Cai</LastName><ForeName>Cui</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>The Central Laboratory, Guangdong Provincial Hospital of TCM, Guangzhou 510120, China. X-Zeng@21cn.com</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zeng</LastName><ForeName>Xing</ForeName><Initials>X</Initials></Author><Author ValidYN="Y"><LastName>Ou</LastName><ForeName>Ai-hua</ForeName><Initials>AH</Initials></Author><Author ValidYN="Y"><LastName>Huang</LastName><ForeName>Yu</ForeName><Initials>Y</Initials></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Xian</ForeName><Initials>X</Initials></Author></AuthorList><Language>chi</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>China</Country><MedlineTA>Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi</MedlineTA><NlmUniqueID>101139110</NlmUniqueID><ISSNLinking>1007-8738</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D017252">CD3 Complex</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015704">CD4 Antigens</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016827">CD8 Antigens</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D017252" MajorTopicYN="N">CD3 Complex</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015704" MajorTopicYN="N">CD4 Antigens</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016516" MajorTopicYN="N">CD4-CD8 Ratio</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016827" MajorTopicYN="N">CD8 Antigens</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003289" MajorTopicYN="Y">Convalescence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005434" MajorTopicYN="N">Flow Cytometry</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005500" MajorTopicYN="N">Follow-Up Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018655" MajorTopicYN="N">Lymphocyte Count</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D045169" MajorTopicYN="N">Severe Acute Respiratory Syndrome</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016176" MajorTopicYN="N">T-Lymphocyte Subsets</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2004</Year><Month>6</Month><Day>15</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2004</Year><Month>12</Month><Day>16</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2004</Year><Month>6</Month><Day>15</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">15193228</ArticleId></ArticleIdList></PubmedData></pubmed><affiliations><list><country><li>République populaire de Chine</li></country><region><li>Guangdong</li></region><settlement><li>Jiangmen</li></settlement></list><tree><noCountry><name sortKey="Huang, Yu" sort="Huang, Yu" uniqKey="Huang Y" first="Yu" last="Huang">Yu Huang</name><name sortKey="Ou, Ai Hua" sort="Ou, Ai Hua" uniqKey="Ou A" first="Ai-Hua" last="Ou">Ai-Hua Ou</name><name sortKey="Zeng, Xing" sort="Zeng, Xing" uniqKey="Zeng X" first="Xing" last="Zeng">Xing Zeng</name><name sortKey="Zhang, Xian" sort="Zhang, Xian" uniqKey="Zhang X" first="Xian" last="Zhang">Xian Zhang</name></noCountry><country name="République populaire de Chine"><region name="Guangdong"><name sortKey="Cai, Cui" sort="Cai, Cui" uniqKey="Cai C" first="Cui" last="Cai">Cui Cai</name></region></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/SrasV1/Data/PubMed/Checkpoint
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002878 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd -nk 002878 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= SrasV1
|flux= PubMed
|étape= Checkpoint
|type= RBID
|clé= pubmed:15193228
|texte= [Study on T cell subsets and their activated molecules from the convalescent SARS patients during two follow-up surveys].
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/RBID.i -Sk "pubmed:15193228" \
| HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd \
| NlmPubMed2Wicri -a SrasV1
| This area was generated with Dilib version V0.6.33. |  |